Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study
Event:
ESC Congress 2022
Topic:
Anticoagulants
Session:
Challenges and advances in antithrombotic therapy
